量化“四大天王”、林园、杨东等明星私募都来抢……

Core Viewpoint - The recent IPO of North Chip Life has attracted significant interest from well-known private equity firms, indicating a recovery in market sentiment and an increase in institutional participation in new stock subscriptions [1][10]. Group 1: Subscription Results - North Chip Life announced that the final strategic placement quantity was 11.4 million shares, accounting for 20% of the total issuance [2][11]. - After the adjustment mechanism was activated, the final offline issuance quantity was 31.92 million shares, representing 70% of the remaining shares after strategic placement [2][11]. - The online issuance quantity was 13.68 million shares, making up 30% of the remaining shares after strategic placement [2][11]. Group 2: Participation of Private Equity Firms - Notable private equity firms such as Mingyuan Investment, Huafang Quantitative, Jiukun Investment, Lingjun Investment, Linyuan Investment, and Ningquan Asset were included in the allocation list for North Chip Life [1][10]. - Ningquan Asset's products collectively received 30,700 shares, amounting to 538,500 yuan; Linyuan Investment's products received 4,416 shares, totaling 77,400 yuan; and Hainan Xiwa's products received 20,100 shares, totaling 353,000 yuan [3][12]. Group 3: Market Trends and Insights - As of January 30, 2026, a total of 159 private equity firms participated in the offline subscription of five newly listed stocks, with a total allocation of 15.76 million shares and a total investment amount of 338 million yuan [6][15]. - The most significant allocation was for Hengyun Chang, a leading domestic semiconductor equipment component company, with 1.236 million shares allocated, amounting to 11.4 million yuan [16][17]. - The increase in enthusiasm for new stock subscriptions is attributed to positive policy signals and a recovering market sentiment, with institutions generally optimistic about market performance in 2026 [7][19].